0001144204-12-032585.txt : 20120628 0001144204-12-032585.hdr.sgml : 20120628 20120530173042 ACCESSION NUMBER: 0001144204-12-032585 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20120530 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synthetic Biologics, Inc. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE, STREET 2: SUITE 200 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: (734) 332-7800 MAIL ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE, STREET 2: SUITE 200 CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20061214 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 CORRESP 1 filename1.htm

 

 

May 30, 2012

 

 

VIA EDGAR

United States Securities

and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attention:Jim Rosenberg

Senior Assistant Chief Accountant

 

Re:Synthetic Biologics, Inc. (the “Company”)

Form 8-K filed on May 3, 2012 and Form 8-K/A filed on May 30, 2012

Item 4.02

File No. 001-12584

 

Dear Mr. Rosenberg:

 

Reference is made to the above-captioned filings.

 

We acknowledge that the adequacy and accuracy of the disclosure in our filings is our responsibility. We acknowledge that the staff comments or changes to disclosure do not foreclose the Commission from taking any action with respect to the filings. We further acknowledge that the Company may not assert staff comments as a defense in any proceedings initiated by the Commission or any person under the federal securities laws of the United States.

 

Thank you.

 

  SYNTHETIC BIOLOGICS, INC.
     
  By: /s/ C. Evan Ballantyne
    C. Evan Ballantyne
    Chief Financial Officer

    

 

 

Synthetic Biologics, Inc. 3985 Research Park Drive, Suite 200, Ann Arbor, MI 48108 (t): 734-332-7800 (f): 734-332-7878

 

 

 

 

GRAPHIC 2 image_001.gif GRAPHIC begin 644 image_001.gif M1TE&.#=A3P'$`'<``"'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"P` M````3P'$`(?___]"0D(Z.CKW]^_6UM[OYN_FG)1*2DKFSDK>4E*ME)SF$.:, MI9SF&2EC4EK>UIS>G.;>G+TZ,4)*C!EC8UKFC`B]O<6$G._FE"G>$`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`@(2EKF4LY*2H2M"$+F0@CFO0BM2@A2SHQS"$)S2@@9SHP9C`@9C$H9 MSDH9"(09S@BMSFOOUKU*:UI[K6NM:X1[K0BMQ92UQ>9",6-".AGF]__>]^]" M0EK_]_]*.CI*0D((_P`!"!Q(L*#!@P@3*ES(L*'#AQ`C2IQ(L:+%BQ@S:MS( ML:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-FSASZMS)LZ?/GT"#"AU* MM*C1HTB3*EW*M*G3IU"C2IU*M:K5JUBS:MW*M:O7KV##BAU+MJS9LVC3JEW+ MMJW;MW#CRIU+MZ[=NWCSZMW+MZ_?OX`#"QY,N+#APX@3*U[,N+'CQY`C2YY, MN;+ERY@S:][,N;/GSZ!#BQY-NK3ITZA3JU[-NK7KU[!CRYY-N[;MV[ASZ][- MN[?OW\"#"Q].O+CQX\B3*U_.O+GSY]"C2Y].O;KUZ]BS:]_.O;OW[^##B_\? M3[Z\Z0'FOQ;8]\0*`2M/['C9I*B^%R_QXMD9P-]F`2M91`(%%`&"`D&8(HLK[MB/C3L&V:.*#=8H8T(%=/B!@/(42`$45&3! M8$H%C&A!B5<^$0\&S%2`P29<<5#SA@)X"?+`0`Z[(Z<`^B.J9J)R/OAFIFY'H$PFD`=B9 MT`=Z!L!G`0ZTX0^DCI8J`#]/_"FIJ:O*R2>GD_+_>5`3D?SICP0!J!H`%+*2 M5,![5P9K@056E)#?`UXH<@L&RR[KI9<8E!E/DBT]P<`!<^::*YRYWIJK/%GH M`\`34+@I@;F1/('D!P'<*L"Y4*@K#Z$.9*%0%FV>*X`#!3"0;[8!Z*NMP-OJ M^\$`G&;+CZ8(Y7FN!/[P8\&=Y08,,,$6<^NF/(*^^^;`%X?\KH7L#AS`Q`41 MP``4<6K;ILO<.O"!NB*-V(2P-Q.@\Q/[%,!?/!H@\(`&02/`+`9>,N-%"1&4 M,"-*!5RJ+9R$N@SQR3GZT^[4]B*$+\R>`@!JKKAN*T\_"?D[-;\*N/PRMV^# M#/,'_7`Z]0$,'_2!UMOB_RWVO"];''C<,"\ZJ-QP4SWUX`)82(7B<.8=]:B) MQPWWRY6"].#--P\+WQ,,#J!//V@6U,_I`]@!M!<(;!'!&[!'0$`!:)>4Y^"[ M?L```Q\0R"W?!Z"L]LNX]DJ0%6QN&S`#`A50<<%M1O)T05^;W:_;8&.O_0<% MV$WUPHI!])*H$!89<,"U`+)$U07JZZ5A!]7!%RZ1,(`XY2&V_DX>F MG*W+>`/!E\86E1`_PM2TH>%,BGF0GG`X@2814$E=V(E?B!,#_@%&:3IG$0Z1%K-0Y M]SRAGAU!XQ,,F`S8.6V<&P[80?Y*,=M M%0J%:L/5OF19$#^]#9+^)$@EK;&+D0<+Z7$]%"5L M:NXL2`&<&$%LF91Y!,F"2MO4S818`&PAM&1"M M0H5(/#5V`+'*U'T"2=XS:TI!]\`'/AK9AQ4ZUX2=.3:A:&1:,-N86(D0J"KM)DW!S`/FN62`'%*A`_/"P`T)\@+P>Y+1]&RYQ M7TE3`+A4>1^XKTGL.*R;N<>Z5+)`!#P`.QQ?1(E,M1R+96:%SW9O<=C3GT$6 M2S;F$6"VN?(C`'B;6I8>KZ0'V]0UXR;#J\TU3OSX%(`OQ\[]=LM-4D:(*;6K M$';!R?];$VM"@Y>G8I*0M[/_LW))^B%:V$&@S@_I%Q_CZS8'"_6*,K0IL M05(@^G#SMCIZ8/;E\;>+\X*MODQKVVZ)/C9;WC(*!-`)76@$L*J`@`.=(&CBI5H'4'"6\3>M M![FC2:_=['P%P+\N3G:[J#`\%B;6D8&CVZ;??,G3F?WLM^M6F`4R+XW%R^P" M/SO<%_)3A9=6VMKZ%)0%(%Z&-.$#@`_\5#%"`&'IS`ZWGK$:8>>!Q"MDLT3$ M:&('$&GEW?JP9EM(HUTF\8%4'D[)4ZFE#8)IEW5<;^6D[%!)Z&X+$5)YHZ<( M69^I8BIJRTX[9:9"3OLFWSZ5L[8N;4F>\+H0@$XB5RA0:@ND>H%(NZN472OD MH%YU;F%=;&==7,P2#]QV24#L'O]>__,/;#[O'HYJU*\(D[4U^(-P5UO"(VR[ M#(P0`E@N_1>I,;',^S^7#"`"7P`!;A0"\1`1E,8MLG80&!\J#3P[R?-/&`!;`(.W!`(-2<;JW$;^R(`,`!UOP M`':P'RZ1``W0`!NP`0G@>`8!6R9#7\RU)/@3,QY5?4YHB6MV?;4(:U[72%>H M;L-57..G`(_TA5&X->N#/3/X=J2 MB01A?UNVA)<6,*8W<,152%QH3W($3?HP8.VX/E=0=2\C'/?5XZP-GYYPE@3@V+]2#59Y#;G MPFR3M(X!T'[D-#@"Q2@N>',E!4HB-1)/P`9RP`8%J0%:X)CP@(PE@1[Q\`C+ MR(RV\(\'8054]#%4PRV1T`0H:5%8Y&A0T)$0)P'OJ(F&U(DY@CVA^)>CN!"V M%P!^,P`22&:6$S>KB8+AB$Z"\XL=E`58]"?Z,B?RH`!^&1)VH`5L@`=&:90& MF0*2Z2L&8`"VL(P9L(P%.!$!F06`IX\#_P)X"O($H_E-&9(%$U)G-J*>ZCE^ M(Q)R$K*>U[4/\^F>5H"2`.*>$P*-3\"?_9DC(>>>[:F>!7J?]YEX$`*@*@8C MZCF?DXD:`[6;!%)V$%'P$'\&"CBLF8'XH`1:D!=C`C=(@1HU29V6D+V]D`AG@G M&3&$O,&D)C&0>"`'T"F=(:H&U:D1XZ0/!I"B*IH>+S&,SKF8(0JB'FJ,)B@1 M^G`/(O`$'9"B&=`!9^*47IH2`V`%BAFET9FG\&"E';$/:S`']["E1VH+C_`% M-#JG5`4'SXD'T/_)!A_*F!ZZI_O1('0X2D&J#_O@!@"@#_H@`FOPIX[P!->9 M'SYSJ)L*0*`CE!4Q)151)67DI`G1#SVC$:XZ.[!*2J!#`#USJY.4)%:)=#>`!2@B$:IG/#"`]X``*,VJA:0`?.6;'/R9AT8`_P,`AJH`;V,`@/ MH`]ND`@GFZTE^Z>-P`%HP`&,,#H0805X"!-,UP3(*J6, MNK826[%X(+$26[NURU\6[)S,`'ZWFH=*J@,WX)_X$GG>L06="&`S&]%@4%%)`@ M\`&Z(?$$:C"V>#`!98N[MKNVM3L$51!Y2H!V]L\GSL1O#A.93A0 M?V<@%+P2`W`'36`/\\`"\RN_]U`G$ST80@9DP2_&$'#S`/>+`"$S#'*P`"$\`"`&[BL0?G)./8NN#_^1O&+\5;43-5``NO)JO9OI#W1T19'X$$LE97@B`*D; M$0ACN@XA*#%&O4D5$?T@(#,2;4`Y$W]E!U8`!_80QW%,OQ,@Q[A\R_8`LG6P M"(Z@J4HZ$?:WO@+R5>ZKKA6!E?3U`4_RR8=(+JJ%(%`PNA)A`0=B<#.[JN/9 M.[4"O@! MOD%APG**T1;-$!P-$ADT$"%])^+2'_SQ5Z*3TF*CI$DW$`)4R!WM$:533W_O M)=$-XK%)4B4"724YC=,UO=+!3,DQC1(M+=(HG22Y:@4U9F-212V4*M$D?2=" M/=3I91"D$UAB\U?K(=#\IS-YUC,>&\R`9=54'1-H@C80U=*T(SKZ<(9L;=*2 M1+QR&LQE71-873M^)=9+5A`CW<]U/9E0#6T>74=_7=B&?=B(G=B*O=B,W=B. M_=B0'=F2/=F47=F6?=F8G=F:O=F_=F@'=JB/=JD7=JF?=JHG=JJO=JL MW=JN_=JP'=NR/=NT7=NV?=NXG=NZO=N\W=N^_=O`'=S"/=S$7=S&?=S(G=S* 0O=S,W=S._=S0'=VL$1``.S\_ ` end